Summary relative risk (SRR) for cancers other than NMSC among those with prior NMSC, compared with those with no prior NMSC
| NMSC | SRR (95% CI)* | I2 |
|---|---|---|
| Individual-level cohort studies (n = 3) | 1.49 (1.12-1.98) | 92% |
| Registry-based studies (n = 12) | 1.12 (1.07-1.17) | 93% |
| Males (n = 12) | 1.14 (1.09-1.20) | 89% |
| Females (n = 12) | 1.10 (1.04-1.15) | 79% |
| BCC (n = 7) | 1.09 (1.01-1.17) | 95% |
| Males (n = 7) | 1.09 (1.00-1.18)† | 93% |
| Females (n = 7) | 1.09 (1.02-1.16) | 82% |
| SCC (n = 7) | 1.17 (1.12-1.23) | 78% |
| Males (n = 7) | 1.20 (1.15-1.26) | 61% |
| Females (n = 7) | 1.09 (1.00-1.19) | 75% |